China Launches First Commercial Insurance for Brain-Computer Interface Surgery
SCMP · 1 SOURCESabout 2 hours ago2 MIN
Summary
China's state-backed push into brain-computer interface technology accelerated this week as the country's largest property insurer launched the nation's first commercial insurance product covering BCI surgery. PICC Property and Casualty, a state-owned insurer, signed the policy with a hospital affiliated with Zhejiang University School of Medicine in Hangzhou, a major tech hub in eastern China . The breakthrough sent ripples through financial markets, with BCI-linked stocks climbing on investor optimism that insurance coverage would accelerate commercialization of the technology .
Key Points
- PICC Property and Casualty announced China's first commercial BCI insurance policy on Wednesday, covering invasive brain surgery required to implant brain chips
- The policy was signed with Zhejiang University School of Medicine's affiliated hospital in Hangzhou, a tech hub home to AI firm DeepSeek and robotics company Unitree Robotics
- Hong Kong-listed BCI stocks rose 1.59 percent on Wednesday, with Shanghai Heartcare Medical Technology gaining 1.28 percent and BrainAurora Medical Technology climbing 1.65 percent
- BCI technology requires open-skull surgery to implant electrodes that allow patients to control digital devices using their thoughts alone
- The technology, championed by Elon Musk's Neuralink, has shown promise in helping paralyzed patients regain mobility
Why It Matters
The insurance breakthrough represents a critical step in China's coordinated effort to overtake Western competitors in the BCI race. By addressing one of the major barriers to adoption—insurance coverage—Beijing is signaling its commitment to nurturing the technology's development, potentially creating new investment opportunities in Hong Kong-listed healthcare and technology companies .
The insurance breakthrough represents a critical step in China's coordinated effort to overtake Western competitors in the BCI race. By addressing one of the major barriers to adoption—insurance coverage—Beijing is signaling its commitment to nurturing the technology's development, potentially creating new investment opportunities in Hong Kong-listed healthcare and technology companies .